ADVANCED MIC.DEV. DL-,01/ US0079031078 /
2024-11-06 8:04:23 PM | Chg. +4.720 | Volume | Bid8:05:37 PM | Ask8:05:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
134.460EUR | +3.64% | 22,901 Turnover: 3.07 mill. |
134.360Bid Size: 475 | 134.480Ask Size: 475 | 214.34 bill.EUR | - | - |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...